Clinical correlations between treatment with anticoagulants/antiaggregants and late rectal toxicity after radiotherapy for prostate cancer

Anticancer Research

Volumn 29, Issue 5, 2009, Pages 1831-1834

  Takeda, Ken ^a   Ogawa, Yoshihiro ^a   Ariga, Hisanori ^a   Koto, Masashi ^a   Sakayauchi, Toru ^a   Fujimoto, Keisuke ^a   Narazaki, Kakutaro ^a   Mitsuya, Masatoshi ^a   Takai, Yoshihiro ^a   Yamada, Shogo ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Late toxicity; Prostate cancer; Radiotherapy; Rectal toxicity

Indexed keywords

ANDROGEN; ANTICOAGULANT AGENT; SERENIC AGENT;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; IRRADIATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RECTAL TOXICITY; RECTUM DISEASE; TOXICITY; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; ANTICOAGULANTS; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROSTATIC NEOPLASMS; RADIOTHERAPY; RECTUM;

EID: 67650088334     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Skwarchuk MW, Jackson A, Zelesky MJ, Venkatraman ES, Cowen DM, Levegrün S, Burman CM, Fuks Z, Leibel SA and Ling CC: Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. Int Radiat Oncol Biol Phys 47: 103-113, 2000.
2. Schultheiss TE, Lee WR, Hunt MA, Hanlon AL, Peter RS and Hanks GE: Late GI and GU complications in the treatment of prostate cancer. Int Radiat Oncol Biol Phys 37: 3-11, 1997. (Pubitemid 27090129)
3. Lawton CA, Bae K, Pilepich M, Hanks G and Shipley W: Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02. Int Radiat Oncol Biol Phys 70: 437-441, 2008.
4. Liu M, Pickles T, Agranovich A, Berthelet E, Duncan G, Keyes M, Rwan W, McKenzie M, Morris J, Pai H, Tyldesley S and Wu J: Impact of neoadjuvant androgen ablation and other factors on late toxicity after external beam prostate radiotherapy. Int Radiat Oncol Biol Phys 58: 59-67, 2004. (Pubitemid 38010337)
5. Herold DM, Halon AL and Hanks GE: Diabetes mellitus: a predictor for late radiation morbidity. Int Radiat Oncol Biol Phys 43: 475-479, 1999. (Pubitemid 29107163)
6. Zelefsky MJ, Cowen D, Fuks Z, Shike M, Burman C, Jackson A, Venkatramen ES and Leibel SA: Long-term tolerance of high-dose three-dimensional conformai radiotherapy in patients with localized prostate carcinoma. Cancer 85: 2460-2468, 1999. (Pubitemid 29244857)
7. Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A and Amols HI: Incidence of late rectal and urinary toxicities after three-dimensional conformai radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int Radiat Oncol Biol Phys 70: 1124-1129, 2008. (Pubitemid 351296130)
8. Sanguineti G, Agostinelli S, Foppiano F, Franzone P, Garelli S, Marcenaro M, Orsatti M and Vitale V: Adjuvant androgen deprivation impacts late rectal toxicity after conformai radiotherapy of prostate carcinoma. Br J Cancer 86: 1843-1847, 2002. (Pubitemid 34888616)
9. Choe KS, Jani AB and Liauw SL: Should radiation therapy be modified for prostate cancer patients on anticoagulants? Int Radiat Oncol Biol Phys 69(Suppl): 313-314, 2007.
10. Vavassori V, Claudio F, Rancati T, Magli A, Fellin G, Baccolini M, Bianchi C, Cagna E, Mauro FA, Monti AF, Munoz F, Stasi M, Franzone P and Valdagni R: Predictors for rectal and intestinal acute toxicities during prostate cancer high-dose 3D-CRT: results of a prospective multicenter study. Int Radiat Oncol Biol Phys 67: 1401-1410, 2007.
11. Fiorino C, Fellin G, Rancati T, Vavassori V, Bianchi C, Borca VC, Girelli G, Mapelli M, Menegotti L, Nava S and Valdagni R: Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study. Int Radiat Oncol Biol Phys 70: 1130-1137, 2008. (Pubitemid 351296107)
12. Britton KR, Takai Y, Mitsuya M, Nemoto K, Ogawa Y and Yamada S: Evaluation of inter- and intrafraction organ motion during intensity modulated radiation therapy (IMRT) for localized prostate cancer measured by a newly developed onboard image-guided system. Radiat Med 23(1): 14-24, 2005. (Pubitemid 40410219)
13. Cox JD, Stetz J and Pajak TF: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int Radiat Oncol Biol Phys 31: 1341-1346, 1995.
14. Lawton CA, Won M, Pilepich MV, Asbell SO, Shipley WU, Hanks GE, Cox JD, Perez CA, Sause WT and Doggett SR: Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. Int Radiat Oncol Biol Phys 21: 935-939, 1991.
15. Shimizu N, Okamoto H, Fukuda T, Yane K and Hosoi H: Late laryngeal radionecrosis in severe arteriosclerosis. J Laryngol Otol 119(11): 922-925, 2005. (Pubitemid 41686599)